Research progress in chronic kidney disease with hepatitis C virus infection

Patients with chronic kidney disease (CKD) are susceptible to hepatitis C virus (HCV) infection due to hemodialysis and kidney transplantation. Despite the progress in treatment and new medicines for hepatitis C, the efficacy, tolerability, and safety of medicines in CKD patients remain unclear. This article reviews the current situation of HCV infection in CKD patients, methods for evaluating liver condition in HCV-CKD patients, and the latest progress in HCV-CKD treatment. More clinical practice is needed to verify the selection and dosage of medicines for HCV-CKD.